Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Feb 25

PMID 22363512

Citations 42

Authors

Vasantha Kumar Bhaskara

Indra Mohanam

Jasti S Rao

Sanjeeva Mohanam

Affiliations

Soon will be listed here.

Abstract

Background: Neuroblastomas are the most common extracranial solid tumors in children. Neuroblastomas are derived from immature cells of the sympathetic nervous system and are characterized by clinical and biological heterogeneity. Hypoxia has been linked to tumor progression and increased malignancy. Intermittent hypoxia or repeated episodes of hypoxia followed by re-oxygenation is a common phenomenon in solid tumors including neuroblastoma and it has a significant influence on the outcome of therapies. The present study focuses on how intermittent hypoxia modulates the stem-like properties and differentiation in neuroblastoma cells.

Methods And Findings: Cell survival was assessed by clonogenic assay and cell differentiation was determined by morphological characterization. Hypoxia-inducible genes were analyzed by real-time PCR and Western blotting. Immunofluorescence, real-time PCR and Western blotting were utilized to study stem cell markers. Analysis of neural crest/sympathetic nervous system (SNS) markers and neuronal differentiation markers were done by real-time PCR and Western blotting, respectively. Intermittent hypoxia stimulated the levels of HIF-1α and HIF-2 α proteins and enhanced stem-like properties of neuroblastoma cells. In intermittent hypoxia-conditioned cells, downregulation of SNS marker genes and upregulation of genes expressed in the neural crest were observed. Intermittent hypoxia suppressed the retinoic acid-induced differentiation of neuroblastoma cells.

Conclusions: Our results suggest that intermittent hypoxia enhances stem-like characteristics and suppresses differentiation propensities in neuroblastoma cells.

Citing Articles

Cellular Systems for Colorectal Stem Cancer Cell Research.

Grigoreva T, Kindt D, Sagaidak A, Novikova D, Tribulovich V Cells. 2025; 14(3).

PMID: 39936962 PMC: 11817814. DOI: 10.3390/cells14030170.

Targeted intracellular delivery of molecular cargo to hypoxic human breast cancer stem cells.

Makela A, Tundo A, Liu H, Schneider D, Hermiston T, Khodakivskyi P bioRxiv. 2024; .

PMID: 39605477 PMC: 11601403. DOI: 10.1101/2024.01.12.575071.

Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies.

Ciepla J, Smolarczyk R Clin Exp Med. 2024; 24(1):235.

PMID: 39361163 PMC: 11449960. DOI: 10.1007/s10238-024-01501-1.

Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade.

Tatrai E, Randelovic I, Surguta S, Tovari J Cancers (Basel). 2024; 16(10).

PMID: 38791951 PMC: 11120288. DOI: 10.3390/cancers16101872.

Metabolic priming by multiple enzyme systems supports glycolysis, HIF1α stabilisation, and human cancer cell survival in early hypoxia.

Grimm F, Asuaje A, Jain A, Silva Dos Santos M, Kleinjung J, Nunes P EMBO J. 2024; 43(8):1545-1569.

PMID: 38485816 PMC: 11021510. DOI: 10.1038/s44318-024-00065-w.

References

Chaudary N, Hill R . Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors. Lab Invest. 2009; 89(5):587-96. DOI: 10.1038/labinvest.2009.16. View

Ross R, Spengler B . Human neuroblastoma stem cells. Semin Cancer Biol. 2006; 17(3):241-7. DOI: 10.1016/j.semcancer.2006.04.006. View

Toffoli S, Michiels C . Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J. 2008; 275(12):2991-3002. DOI: 10.1111/j.1742-4658.2008.06454.x. View

Holmquist L, Lofstedt T, Pahlman S . Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models. Adv Exp Med Biol. 2006; 587:179-93. DOI: 10.1007/978-1-4020-5133-3_16. View

Louie E, Nik S, Chen J, Schmidt M, Song B, Pacson C . Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res. 2010; 12(6):R94. PMC: 3046435. DOI: 10.1186/bcr2773. View

Moeller B, Richardson R, Dewhirst M . Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev. 2007; 26(2):241-8. DOI: 10.1007/s10555-007-9056-0. View

Semenza G . Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol. 2000; 35(2):71-103. DOI: 10.1080/10409230091169186. View

Holmquist L, Jogi A, Pahlman S . Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells. Int J Cancer. 2005; 116(2):218-25. DOI: 10.1002/ijc.21024. View

Aldinucci C, Maiorca S, De Rosa P, Palmi M, Sticozzi C, Ciccoli L . The physiological behaviour of IMR-32 neuroblastoma cells is affected by a 12-h hypoxia/24-h reoxygenation period. Neurochem Res. 2010; 35(11):1691-9. DOI: 10.1007/s11064-010-0231-2. View

10.

Dewhirst M . Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res. 2007; 67(3):854-5. DOI: 10.1158/0008-5472.CAN-06-4744. View

11.

Li C, Jackson R . Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002; 282(2):C227-41. DOI: 10.1152/ajpcell.00112.2001. View

12.

Liu Y, Song X, Wang X, Wei L, Liu X, Yuan S . Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells. J Cell Biochem. 2010; 111(3):554-63. DOI: 10.1002/jcb.22739. View

13.

Malec V, Gottschald O, Li S, Rose F, Seeger W, Hanze J . HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med. 2010; 48(12):1626-35. DOI: 10.1016/j.freeradbiomed.2010.03.008. View

14.

Maris J . The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr. 2005; 17(1):7-13. DOI: 10.1097/01.mop.0000150631.60571.89. View

15.

Nilsson M, Zage P, Zeng L, Xu L, Cascone T, Wu H . Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors. Oncogene. 2010; 29(20):2938-49. DOI: 10.1038/onc.2010.60. View

16.

Jogi A, Ora I, Nilsson H, Lindeheim A, Makino Y, Poellinger L . Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A. 2002; 99(10):7021-6. PMC: 124521. DOI: 10.1073/pnas.102660199. View

17.

Li Z, Bao S, Wu Q, Wang H, Eyler C, Sathornsumetee S . Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 2009; 15(6):501-13. PMC: 2693960. DOI: 10.1016/j.ccr.2009.03.018. View

18.

Durand R, Aquino-Parsons C . Clinical relevance of intermittent tumour blood flow. Acta Oncol. 2002; 40(8):929-36. DOI: 10.1080/02841860152708206. View

19.

Kim Y, Lin Q, Zelterman D, Yun Z . Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res. 2009; 69(24):9271-80. PMC: 2828615. DOI: 10.1158/0008-5472.CAN-09-1605. View

20.

Hsieh C, Lee C, Liang J, Yu C, Shyu W . Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity. Oncol Rep. 2010; 24(6):1629-36. DOI: 10.3892/or_00001027. View